Immediate Impact
4 from Science/Nature 48 standout
Citing Papers
The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing
2024 Standout
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
2024 Standout
Works of Hank Safferstein being referenced
A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hank Safferstein | 58 | 91 | 19 | 45 | 6 | 137 | |
| Kelsie Mozzoni | 50 | 68 | 17 | 38 | 5 | 107 | |
| Inge Snoeren | 23 | 108 | 11 | 57 | 9 | 203 | |
| Chiara Contri | 50 | 79 | 7 | 32 | 10 | 225 | |
| Elena Speretta | 47 | 92 | 20 | 83 | 7 | 185 | |
| Raymond Yurko | 31 | 98 | 8 | 25 | 6 | 132 | |
| Alberto Santiago-Balmaseda | 31 | 92 | 26 | 101 | 5 | 208 | |
| Barbara Vogg | 36 | 70 | 36 | 77 | 8 | 152 | |
| Tania Mead | 32 | 70 | 20 | 44 | 6 | 168 | |
| Noel Casey | 28 | 43 | 17 | 104 | 7 | 206 | |
| Courtney Rehak | 31 | 58 | 8 | 25 | 5 | 85 |
All Works
Loading papers...